Life Sciences Nova Scotia
  • About
    • Who We Are
    • What we do
    • Why work in Nova Scotia?
    • Contact us
  • Members
    • Member Directory
    • Member Benefits
    • Become a member
  • Resources
    • Member Programs
    • News and success stories
    • Member Job Board
  • Events
    • Events
    • BioPort Atlantic
    • Atlantic Precision Medicine Conference
  • Podcast
Select Page

Research and innovation leading to better outcomes for Canadians living with diabetes

by administrator | May 16, 2018 | News, Novo Nordisk

See original story here In August 1922, 13-year-old Elizabeth Evans Hughes, extremely weak at only 45 pounds, was one of the first patients treated with insulin. It saved her life. She went on to graduate from college, get married and have three children. She died...

Xultophy® approved in Canada for the treatment of adults with type 2 diabetes

by administrator | Apr 18, 2018 | News, Novo Nordisk

See original story here Once-daily Xultophy® has been shown to help patients achieve blood glucose targets Novo Nordisk announced today that Health Canada has approved Xultophy®as an adjunct to lifestyle modifications, for the once-daily treatment of adults with type...

Recent Posts

  • Home + Health Raising Funds for Care and Wellness Platform
  • Digital Nova Scotia and Life Sciences Nova Scotia sign MOU to accelerate digital health and life sciences innovation
  • Three Sperri staff stand in a warehouse in front of boxes of their product
    Sperri Donates 120K Meals to Food Banks
  • Precision BioLogic Acquires George King Bio-Medical
  • Precision lab equipment
    Precision BioLogic Leads the Way in Hemophilia Testing
No comments to show.
[buddybot_chat id=1]

Life Sciences Nova Scotia is the organization to help fuel your success.

Join today
  • WHO WE ARE
  • EVENTS
  • MEMBER PROGRAMS
  • CONTACT US
  • MEMBERS
  • NEWS & SUCCESS STORIES
  • Follow
  • Follow